MCP-1-bindende Nukleinsäuren
Patent europeic · EP2135949 · Stritgà
Inscripziun en il register
- Numer da publicaziun
- EP2135949
- Numer da la dumonda
- EP09012826
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- Stritgà
- Scrittira da patent
- Concedì
- Annunzià
- 14-02-2007
- Publitgà
- 23-12-2009
- Concedì
- 17-10-2012
- Stritgà
- 23-09-2026
- Motiv
- Taxa annuala betg pajada
- Classas IPC
- C12N 15/11 (2006.01)A61K 31/7088 (2006.01)
- Prioritad
- EP 06002935 14.02.2006EP 06024202 22.11.2006
- Derivà da
- EP07722818
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 23-09-2026
Stritgà, taxa betg pajada
- Status of protective title
- Active → Cancelled
- Cancellation date
- 23.09.2026
- Cause for cancellation
- Non-payment of renewal fee
Published in Swissreg on 23.09.2026
- 01-03-2025
Next annual fee due on
- Next annual fee due on
- 28.02.2025 → 28.02.2026
Published in Swissreg on 01.03.2025
- 01-03-2024
Midada
Published in Swissreg on 01.03.2024
- 06-03-2023
Midada
Published in Swissreg on 06.03.2023
- 10-08-2022
Adressa midada
- Owner
- Noxxon Pharma AG, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany → TME Pharma AG, Max-Dohrn-Strasse 8-10, 10589 Berlin, Germany
Published in Swissreg on 10.08.2022
- 28-12-2012
Represchentant inscrit
- Representative
- Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich
Published in Swissreg on 28.12.2012
- 17-10-2012
Concedì
Published in Swissreg on 17.10.2012
Partidas
Represchentant
Inventur
13359 Berlin, DE
13469 Berlin, DE
10247 Berlin, DE
10709 Berlin, DE
14197 Berlin, DE
13509 Berlin, DE
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.